AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

AMOXICILLIN AND CLAVULANATE

10 registrations across 3 African markets— 9 active

Markets with AMOXICILLIN AND CLAVULANATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
SPOT CLAV
Tablet
🇰🇪KenyaSPARSH BIO-TECH PRIVATE LIMITEDactiveSept 2026
MOXICLAV COMBINATION PTODUCT TABLET
TABLET
🇲🇼MalawiexpiredNov 2005
Myclav 375
Tablets
🇹🇿TanzaniaUnichem Laboratories Ltdactive
Augmentin
Tablets
🇹🇿TanzaniaGlaxoSmithKline Trading Services Ltd, Irelandactive
Indclav 228
Powder for Oral suspension
🇹🇿TanzaniaIndchemie Health Specialities Pvt. Ltdactive
Rapiclav 625
Tablets
🇹🇿TanzaniaIPCA Laboratories Limitedactive
Myclav 625
Tablets
🇹🇿TanzaniaUnichem Laboratories Ltdactive
Clavomid 375
Tablets
🇹🇿TanzaniaRemedica LTDactive
Co-AMOXICLAV FOR INJECTION
Powder for Injection
🇹🇿TanzaniaMORAF PHARMACEUTICALS LTDactive
Clavulin tablet
Tablets
🇹🇿TanzaniaGlaxoSmithKline Trading Services Ltd, Irelandactive

AMOXICILLIN AND CLAVULANATE in Africa — Regulatory Overview

AMOXICILLIN AND CLAVULANATE is registered across 3 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Kenya, Malawi. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 9 (90%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.